Tumors of the upper gastro-intestinal tract;Tumoren des oberen Gastrointestinaltrakts: Indikation und Ausmaß der Lymphknotendissektion

Chirurg

Volumn 81, Issue 2, 2010, Pages 103-110

  Sendler, A ^a  

^a Isar Medizin Zentrum   (Germany)

Author keywords

Esophageal cancer; Gastric cancer; Lymphadenectomy; Pancreatic cancer

Indexed keywords

CANCER INVASION; CANCER STAGING; ESOPHAGUS TUMOR; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH TUMOR;

ESOPHAGEAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS;

EID: 77950461309     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-009-1813-x     Document Type: Article

References (44)

1. Akiyama H,Tsurumaru M, Udagawa H et al (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220:364-372
2. Barbier PA, Luder PJ, Schupfer G et al (1988) Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: results of a prospective follow-up in 50 patients.World J Surg 12:270-276
3. Barbour AP, Rizk NP, Gonen M et al (2007) Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 14:306-316
4. Bollschweiler E, Baldus SE, SchroderW et al (2006) Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 94:355-363
5. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340:908-914
6. Bork U, Koch M, Büchler MW,Weitz J (2009) HepatobiliäreTumorchirurgie. Indikation und Ausmaß der Lymphknotendissektion. Chirurg 81
7. Cuschieri A,Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530
8. Degiuli M, Calvo F (2006) Survival of early gastric cancer in a specialized European center.Which lymphadenectomy is necessary?World J Surg 30:2193-2203
9. Degiuli M, Sasako M, Ponti A et al (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90:1727-1732
10. Dent DM, Madden MV, Price SK (1988) Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75:110-112
11. Dresner SM, Lamb PJ, Bennett MK et al (2001)The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 129:103-109
12. Edwards P, Blackshaw GR, LewisWG et al (2004) Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888-1892
13. Farnell MB, Pearson RK, Sarr MG et al (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618-628
14. Feinstein AR, Sosin DM,Wells CK (1985)The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608
15. Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread of Barrett's cancer.World J Surg 27:1052-1057
16. GotodaT,Yanagisawa A, Sasako M et al (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3:219-225
17. GuY, Swisher SG, Ajani JA et al (2006)The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106:1017-1025
18. Hagen JA, DeMeester SR, Peters JH et al (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520-530
19. Hartgrink HH, Jansen EP, Grieken NC van et al (2009) Gastric cancer. Lancet 374:477-490
20. Hartgrink HH,Velde CJ van de (2005) Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 90:153-165
21. Hartgrink HH,Velde CJ van de, Putter H et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077
22. Hölzel D, Engel J, Löhrs U (2008) Sind elektive Lymphknotendissektionen in der Karzinomchiurgie noch zeitgemäß? Zentralbl Chir 133:582-589
23. Hulscher JB, Sandick JW van, Boer AG de et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669
24. Ishikawa O, Ohhigashi H, SasakiY et al (1988) Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208:215-220
25. Kang CH, KimYT, Jeon SH et al (2007) Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg 31:154-160
26. Leers JM, DeMeester SR, Chan N et al (2009) Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 138:594-602
27. LerutT, Nafteux P, Moons J et al (2004)Three field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation ofTNM classification in upper-half esophageal carcinoma. Ann Surg 240:962-972
28. ManabeT, Ohshio G, Baba N et al (1989) Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64:1132-1137
29. McCulloch P, Nita ME, Kazi H et al (2004) Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev CD001964
30. Michalski CW, Kleeff J,Wente MN et al (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265-273
31. NishihiraT, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47-51
32. NishimakiT, SuzukiT, Suzuki S et al (1998) Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186:306-312
33. Pedrazzoli S, Beger HG, Obertop H et al (1999) A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 16:337-345
34. Pedrazzoli S, DiCarloV, Dionigi R et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508-517
35. Peyre CG, Hagen JA, DeMeester SR et al (2008)The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549-556
36. Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979-985
37. Sasako M, SanoT,Yamamoto S et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359:453-462
38. Schwarz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 11:1384-1393
39. Sendler A, Siewert JR (2003) Individualizing therapy in gastric cancer. Expert Rev AnticancerTher 3:457-470
40. Siewert JR, Böttcher K, Stein H et al (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228:449-461
41. Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139-146
42. Stein HJ, Feith M, Bruecher BL et al (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242:566-573
43. Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309-315
44. Yeo CJ, Cameron JL, Lillemoe KD et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355-366